ViiV Healthcare BV
🇳🇱Netherlands
Clinical Trials
0
Active:0
Completed:0
Trial Phases
0 Phases
Drug Approvals
59
CIMA_AEMPS:29
NMPA:15
EMA:15
Drug Approvals
Cabotegravir Sodium Tablets
- Product Name
- 万凯锐
- Approval Number
- 国药准字HJ20230094
- Approval Date
- Jul 11, 2023
NMPA
Dolutegravir Sodium Dispersible Tablets
- Product Name
- 多替拉韦钠分散片
- Approval Number
- 国药准字HJ20230060
- Approval Date
- May 29, 2023
NMPA
Dolutegravir Sodium and Rilpivirine Hydrochloride Tablets
- Product Name
- 多替拉韦利匹韦林片
- Approval Number
- 国药准字HJ20220081
- Approval Date
- Oct 18, 2022
NMPA
Dolutegravir Sodium, Abacavir Sulfate and Lamivudine Tablets
- Product Name
- 绥美凯
- Approval Number
- 国药准字HJ20170345
- Approval Date
- May 23, 2022
NMPA
Abacavir Sulfate Oral Solution
- Product Name
- 赛进
- Approval Number
- 国药准字HJ20150202
- Approval Date
- Jun 8, 2021
NMPA
- Prev
- 1
- 2
- Next
Clinical Trials
No trials found
News
No news found